Literature DB >> 3360691

Characterization of tetracycline-resistant strains of Ureaplasma urealyticum.

J A Robertson1, G W Stemke, S G Maclellan, D E Taylor.   

Abstract

Gel electrophoresis revealed no plasmids in cloned strains of Ureaplasma urealyticum for which minimal inhibitory concentration (MICs) of tetracycline were greater than 64 mg/l. However, DNA from these strains hybridized with the tetM sequence from Streptococcus agalactiae in dot blot hybridization, whilst DNA from more-susceptible strains did not do so. Our results confirm and extend previous work, in which the tetM sequence was associated with resistance to the tetracycline antibiotics in strains of U. urealyticum. The strains examined in this study were isolated primarily in western North America but included representatives from Europe and the United Kingdom. Serotyping showed an increase in strains with the serotype 9 determinant and a decrease in those with the serotype 14 determinant together with a shift to the biotype 2 cluster (P = less than 0.02). To characterize these strains and to identify alternative antibiotics for therapeutic and basic research applications, 26 tetracycline-resistant strains were tested against 25 diverse antimicrobial agents. All demonstrated in-vitro susceptibility to rosaramicin but were resistant to 2 mg/l erythromycin. Only two of the strains were resistant to 16 mg/l erythromycin. Most antibiotics were not active against these isolates, but low concentrations of filipin and unconventional agents such as flurofamide and hydroquinone inhibited the growth of some strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360691     DOI: 10.1093/jac/21.3.319

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Tetracycline resistant mycoplasmas from Thailand and South America.

Authors:  C Roberts; G Jahn; P K Kohl; G E Kenny
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

2.  In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones, and a streptogramin.

Authors:  H Renaudin; C Bébéar; J A Robertson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

3.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

Authors:  G E Kenny; T M Hooton; M C Roberts; F D Cartwright; J Hoyt
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 4.  Alternative therapy for genital mycoplasma infections.

Authors:  J A Robertson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

5.  Detection of tetracycline-resistant strains of Ureaplasma urealyticum by hybridization assays.

Authors:  B Brunet; B de Barbeyrac; H Renaudin; C Bébéar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

6.  Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum.

Authors:  J A Robertson; A Vekris; C Bebear; G W Stemke
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

9.  Clinical and biological characteristics of Ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia.

Authors:  R R Lehmer; B S Andrews; J A Robertson; E J Stanbridge; L de la Maza; G J Friou
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.